#
FusePaq Fanatrex
  • Treatments
  • Pain
  • FusePaq Fanatrex (Oral)

FusePaq Fanatrex (Oral)

Generic name: gabapentin (oral route) [ gab-a-PEN-tin ]
Drug class:Gamma-aminobutyric acid analogs

Medically reviewed by Drugs.com. Last updated on Apr 9, 2022.

Commonly used brand name(s)

In the U.S.

  • FusePaq Fanatrex
  • Gabarone
  • Gralise
  • Neurontin

Available Dosage Forms:

  • Capsule
  • Tablet
  • Tablet, Extended Release, 24 HR
  • Solution
  • Suspension

Therapeutic Class: Anticonvulsant

Chemical Class: Gamma Aminobutyric Acid (class)

Uses for FusePaq Fanatrex

Gabapentin is used to help control partial seizures (convulsions) in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to control seizures for as long as you continue to take it.

Gabapentin is also used to manage a condition called postherpetic neuralgia, which is pain that occurs after shingles.

Gabapentin works in the brain to prevent seizures and relieve pain for certain conditions in the nervous system. It is not used for routine pain caused by minor injuries or arthritis. Gabapentin is an anticonvulsant.

This medicine is available only with your doctor's prescription.

Before using FusePaq Fanatrex

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of gabapentin for treating partial seizures in children 3 years of age and older. However, safety and efficacy have not been established in children younger than 3 years of age...